Phathom Pharmaceuticals, Inc. (PHAT)
CIK 1783183 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Phathom Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 8, 2026 | 4 | 0001193125-26-385250 |
| Jul 30, 2026 | 8-K | 0001193125-26-324865 |
| Jul 30, 2026 | 10-Q | 0001193125-26-324867 |
| Jul 29, 2026 | SCHEDULE 13G | 0002012383-26-002854 |
| Jul 20, 2026 | SCHEDULE 13G/A | 0001104659-26-085122 |
| Jul 16, 2026 | 4 | 0001193125-26-306165 |
| Jun 23, 2026 | 8-K | 0001193125-26-278533 |
| May 27, 2026 | 4 | 0001193125-26-241984 |
| May 21, 2026 | 8-K | 0001193125-26-234379 |
| May 21, 2026 | 4 | 0001193125-26-234566 |
| May 21, 2026 | 4 | 0001193125-26-234891 |
| May 21, 2026 | 4 | 0001193125-26-234567 |
| May 21, 2026 | 4 | 0001193125-26-234572 |
| May 21, 2026 | 4 | 0001193125-26-234568 |
| May 21, 2026 | 4 | 0001193125-26-234563 |
| May 21, 2026 | 4 | 0001193125-26-234564 |
| Apr 30, 2026 | 10-Q | 0001193125-26-193946 |
| Apr 30, 2026 | 8-K | 0001193125-26-193945 |
| Apr 7, 2026 | ARS | 0001193125-26-144576 |
| Apr 7, 2026 | DEF 14A | 0001193125-26-144570 |
| Apr 7, 2026 | DEFA14A | 0001193125-26-144578 |
| Mar 27, 2026 | S-8 | 0001193125-26-128966 |
| Mar 12, 2026 | SCHEDULE 13G | 0001104659-26-027124 |
| Mar 11, 2026 | 4 | 0001193125-26-102632 |
| Mar 3, 2026 | 4 | 0001193125-26-088730 |